Related Experiment Videos
A Meta-Analysis of Alzheimer's Disease Brain Transcriptomic Data
Hamel Patel1,2, Richard J B Dobson1,2,3,4,5, Stephen J Newhouse1,2,3,4,5
1Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Journal of Alzheimer'S Disease : JAD
|March 26, 2019
Summary
This study identified specific gene expression changes in Alzheimer's disease (AD) brains by analyzing transcriptomic data. These findings offer new insights into AD mechanisms and potential therapeutic targets.
Area of Science:
- Neuroscience
- Genomics
- Molecular Biology
Background:
- Microarray studies reveal gene expression imbalances in Alzheimer's disease (AD) brains.
- Lack of reproducibility and overlapping perturbations with other disorders complicate AD transcriptomic research.
Purpose of the Study:
- To meta-analyze transcriptomic data from multiple brain disorders.
- To identify robust gene expression changes specific to Alzheimer's disease.
Main Methods:
- Analyzed 2,667 samples across 22 AD and 11 other brain disorder datasets.
- Utilized differential expression analysis and a meta-analysis method (Adaptively Weighted with One-sided Correction).
- Examined four brain regions: temporal lobe, frontal lobe, parietal lobe, and cerebellum.
Main Results:
- Identified 323-1,023 differentially expressed genes specific to AD in different brain regions.
- Found seven consistently perturbed genes across all AD brain regions, with SPCS1 expression validated.
- Discovered 19 genes specifically altered in brain regions with plaques and tangles.
- Enriched pathways included protein metabolism and viral components in AD brains.
Conclusions:
- This study successfully identified transcriptomic signatures specific to Alzheimer's disease.
- Findings contribute to understanding AD pathogenesis and may reveal novel therapeutic targets.